I Flow Corporation Continues to Enforce Its Patent and Trade Secret Rights against Apex Medical s Solace R Pump Distributed by Zone Medical LLC: related news

I-Flow Corporation Continues to Enforce Its Patent and Trade Secret Rights against...

I-Flow Corporation Continues to Enforce Its Patent and Trade Secret Rights against Apex Medical's Solace(R) Pump Distributed by Zone Medical, LLC LAKE FOREST, Calif.--(Business Wire)-- I-Flow Corporation (NASDAQ: IFLO) continues to enforce its patent and trade secret rights against Apex Medical Technologies, Inc. and its president, Mark McLaughlin, in the United States District Court for the Southern District of California. I-Flow is also enforcing its patent rights against distributors of Apex's Solace(R) Pump, including Zone Medical, LLC. In view of early successes achieved in the lawsuit in the Southern District of California, I-Flow will ask the Court to rule, as a legal matter, that Apex, McLaughlin and Zone have infringed the patent. I-Flow is also vigorously moving forward in the case to protect its valuable trade secrets.

I-Flow Corporation Continues to Enforce Its Patent and Trade Secret Rights against Apex Medical's Solace(R) Pump Distributed by Zone Medical, LLC

LAKE FOREST, Calif. (Business Wire) -- I-Flow Corporation (NASDAQ: IFLO) continues to enforce its patent and trade secret rights against Apex Medical Technologies, Inc. and its president, Mark McLaughlin, in the United States District Court for the Southern District of California. I-Flow is also enforcing its patent rights against distributors of Apex's Solace(R) Pump, including Zone Medical, LLC. In view of early successes achieved in the lawsuit in the Southern District of California, I-Flow will ask the Court to rule, as a legal matter, that Apex, McLaughlin and Zone have infringed the patent. I-Flow is also vigorously moving forward in the case to protect its valuable trade secrets.

I-Flow Corporation Continues to Enforce Its Patent and Trade Secret Rights against Apex Medical's Solace Pump Distributed by Zone Medical, LLC

LAKE FOREST, Calif.--(BUSINESS WIRE)--Oct 11, 2008 - I-Flow Corporation (NASDAQ: IFLO) continues to enforce its patent and trade secret rights against Apex Medical Technologies, Inc. and its president, Mark McLaughlin, in the United States District Court for the Southern District of California. I-Flow is also enforcing its patent rights against distributors of Apex's Solace(R) Pump, including Zone Medical, LLC. In view of early successes achieved in the lawsuit in the Southern District of California, I-Flow will ask the Court to rule, as a legal matter, that Apex, McLaughlin and Zone have infringed the patent. I-Flow is also vigorously moving forward in the case to protect its valuable trade secrets.

I-Flow Corporation Continues to Enforce Its Patent and Trade Secret Rights against Apex Medical's Solace(R) Pump Distributed by Zone Medical, LLC

continues to enforce its patent and trade secret rights against Apex Medical Technologies, Inc. and its president, Mark McLaughlin, in the United States District Court for the Southern District of California. I-Flow is also enforcing its patent rights against distributors of Apex's Solace(R) Pump, including Zone Medical, LLC. In view of early successes achieved in the lawsuit in the Southern District of California, I-Flow will ask the Court to rule, as a legal matter, that Apex, McLaughlin and Zone have infringed the patent. I-Flow is also vigorously moving forward in the case to protect its valuable trade secrets.

I-Flow Corporation Continues to Enforce Its Patent and Trade Secret Rights against Apex Medical's Solace(R) Pump Distributed by Zone Medical, LLC

I-Flow Corporation Continues to Enforce Its Patent and Trade Secret Rights against Apex Medical's Solace(R) Pump Distributed by Zone Medical, LLC

I-Flow Corporation Continues to Enforce Its Patent and Trade Secret Rights against Apex Medical's Solace(R) Pump Distributed by Zone Medical, LLC

I-Flow Corporation (IFLO) continues to enforce its patent and trade secret rights against Apex Medical Technologies, Inc. and its president, Mark McLaughlin, in the United States District Court for the Southern District of California. I-Flow is also enforcing its patent rights against distributors of Apex

I-Flow Corporation Continues to Enforce Its Patent and Trade Secret Rights against Apex Medical's Solace(R) Pump Distributed by Zone Medical, LLC

I-Flow Corporation (NASDAQ: IFLO) continues to enforce its patent and trade secret rights against Apex Medical Technologies, Inc. and its president, Mark McLaughlin, in the United States District Court for the Southern District of California. I-Flow is also enforcing its patent rights against distributors of Apex

I-Flow Corporation Continues to Enforce Its Patent and Trade Secret Rights against Apex Medical's Solace(R) Pump Distributed by Zone Medical, LLC

LAKE FOREST, Calif. - I-Flow Corporation (NASDAQ: IFLO) continues to enforce its patent and trade secret rights against Apex Medical Technologies, Inc. and its president, Mark McLaughlin, in the United States District Court for the Southern District of California. I-Flow is also enforcing it

I-Flow Corporation Continues to Enforce Its Patent and Trade

I-Flow Corporation Continues to Enforce Its Patent and Trade Secret Rights against Apex Medical's Solace(R) Pump Distributed by Zone Medical, LLC

I-Flow Corporation Continues to Enforce Its Patent and Trade Secret Rights against Apex Medical's Solace(R) Pump Distributed by Zone Medical, LLC

Top 10 News Items 10/6-10/10: Dow Plunges 18% This Week; UK to Inject Capital Into Banking System; Iceland Melts-down, Seizes Largest Bank

I-Flow says it Continues to its Enforce Patent and Trade Secret Rights against Apex Medical's Solace Pump Distributed by Zone Medical - Quick facts

I-Flow Receives Multi-Year Contract For ON-Q Pain Relief System From HealthTrust Purchasing Group - Quick Facts

Nikon D90 digital SLR camera

i t r t e p n n s e e f h 2 0 M k N c o s i m, l s r. m s o p o l i w l i g o a d t e a e a. h s r e i f l e w t p o l o t e o e, u o l o e f h m, a a i P r m n, s n h r f c s. i h u e e t i k n a o t t, o k o s e' t e t r, n s m t i g s b u t h p e t h r.

Push to put arts on commercial footing

U i e s t e o f r n p s g a u t c u s s n e e r h n c m e c a i a i n k l s r l o i g o n r a e h i a p a t a t a d u a i i s t d n s n a s s t i c h r i d v l p n g e t r u i e s c m n.

Halliburton Applies For Patent-Trolling Patent

An anonymous reader writes "Halliburton, the company many folks know as Dick Cheney's previous employer, has apparently taken an interest in methods of patent trolling. In fact, according to Techdirt, the company has applied for a patent on patent trolling. Specifically, it's applied for a patent on the process of finding a company that protected an invention via trade secret, figuring out what that secret is, patenting it ... and then suing the original company. Hopefully, the patent office rejects this patent, because I somehow doubt that Halliburton is trying to get the patent as a way to block others from patent trolling."

Sour grapes over BlackBerrys

C a f e r d i o s n s n b s n s c a s i t a e a e e l- s d r p i g o p r i m n a y e v c , b t e e a p l t c a s p e r o a e a l t l s c e s n h i e i f g t i h u e u r t t g t n p r c r o a e x c t v s a e o g a t d - B a k e r .

Revolutions Medical Patent News

Revolutions Medical Corporation (OTCBB: RMCP – News) is pleased to report that it has recently received a notice of allowance through its patent attorney Richard Moseley from the United States Patent and Trademark Office for issuance as a patent for its Rev Vac Safety syringe. This patent will be issued shortly and will be the second US patent protecting its proprietary Rev Vac Safety Syringe. Ron Wheet, CEO of Revolutions Medical states "the timing couldn't be any better. As we await clearance from the FDA on our pre-market 510k application for our Rev Vac Safety Syringe, we now will have two strong US patents protecting our proprietary technology. In addition, we have also spent the time and money necessary to protect our US patents internationally over the last 6 months.

Power3 Medical files two patent applications for breast cancer blood test

Add our medical news to StumbleUpon - Power3 Medical files two patent applications for breast cancer blood test Add our medical news to Facebook - Power3 Medical files two patent applications for breast cancer blood test

Google re-engineers deal

R s o d n t g o i g n i- r s c n e n , i t r e s a c k n G o l h s r m t c l y e h p d t p o o e o l n a v r i i g i -u w t Y h o! n b d o a e h c n r v r i l e l.

What do you look for in an XML editor?

I've been thinking about XML editors lately, because it seems whenever I write XML these days there's an unencoded ampersand (& that isn't written &) or something else that breaks the document when I load. This is really frustrating. I had been using XMLSpy when I worked at a corporation, and that program is great. But it's extremely expensive for a self-employed freelancer like myself, so I don't have it any longer. I wish I still had it so I could write a review of it, as I did like it then... Anyway, since then, I've been writing my XML either in standard text editors (thus the well-formed problem above) or in Komodo Edit (which is great, and I'm working on a review of it...). But I'm curious what other people look for in an XML editor.

Games to console the whole family

h s a r n c a a t r r m e S n t t e i t e i P a e i l a i g h $U 4 b l i n ($ 3 i l o ) g m n i d s r 's f o t i h u e o d n e t i m n i t e u -u t t e e t v s a o .

Bond on Sony sales mission

S n A s r l a s o n i g n n l b r t m r e i g a p i n u l a o n t e e J m s o d i m u n u o S l c t h l l f s l s u i g h t t r d c s i l e t u h h i t a r t i i g e s n.

Nomir Medical Technologies Granted European Patent on Core Noveon(R) Technology

Nomir Medical Technologies, a leader in the development of optical energy technologies for medical applications, announced today that The European Patent Office has granted a patent to Nomir which protects its core Noveon(R) technology. The Noveon is a light-based system that targets the elimination of bacterial and fungal infections through a unique near-infrared photo-inactivation effect, while preserving healthy tissue and promoting recovery.

Court Stays Patent Infringement Suit Brought against Candela byPalomar

Candela Corporation (NASDAQ: CLZR) announced today that the United States District Court for the District of Massachusetts agreed to stay the patent litigation that Palomar Medical Technologies, Inc. (�Palomar�) brought against the Company in August 2006. In that suit, Palomar asserts that the Company infringed upon U.S. Patent No. 5,735,844 (the ‘ “844 Patent�) and U.S. Patent No. 5,595,568, which is related to the ‘844 Patent (the ‘ “568 Patent�).

Court Stays Patent Infringement Suit Brought against Candela by Palomar

Candela Corporation (NASDAQ: CLZR) announced today that the United States District Court for the District of Massachusetts agreed to stay the patent litigation that Palomar Medical Technologies, Inc. (�Palomar�) brought against the Company in August 2006. In that suit, Palomar asserts that the Company infringed upon U.S. Patent No. 5,735,844 (the ‘ “844 Patent�) and U.S. Patent No. 5,595,568, which is related to the ‘844 Patent (the ‘ “568 Patent�).

Search took 1.66 seconds.